NVAX
Novavax, Inc. · Healthcare · Biotechnology
Momentum-Eingaben (vergleichbare Manager):
Halterbreite +11.8% ·
Aktienfluss +4.0% ·
neue Nettopositionen +10.5%
· Formel
Breite Akkumulation: steigende Aktienanzahl bei mehr Inhabern
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q3 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 11.12K | $122,475 | n/a | −1 |
| Q2 2026 | 98 | +3 | 79.12M | $745.13M | +11 | −8 |
| Q1 2026 | 98 | +8 | 80.71M | $656.76M | +12 | −4 |
| Q4 2025 | 89 | -3 | 88.45M | $594.43M | n/a | −3 |
| Q3 2025 | 19 | +2 | 55.31M | $479.50M | +2 | n/a |
| Q2 2025 | 14 | 0 | 51.16M | $322.31M | n/a | n/a |
| Q1 2025 | 11 | +1 | 21.46M | $137.59M | +1 | n/a |
| Q4 2024 | 10 | -2 | 20.61M | $165.71M | n/a | −2 |
| Q3 2024 | 11 | +2 | 17.18M | $216.96M | +2 | n/a |
| Q2 2024 | 9 | n/a | 15.07M | $190.77M | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 15.19M | -1.6% | $131.74M | 0.0% | ▼ Trim | 2 | SEC ↗ ×6 |
| 2 | BlackRock ✦ (passiv) | 12.77M | +0.2% | $110.74M | 0.0% | ▲ Add | 2 | SEC ↗ ×12 |
| 3 | State Street Global Advisors ✦ (passiv) | 7.20M | +5.5% | $62.40M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 4 | D. E. Shaw & Co. ✦ | 4.27M | +8.4% | $37.06M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 5 | Coatue Management ✦ | 3.84M | 0.0% | $33.27M | 0.1% | Held | 3 | SEC ↗ |
| 6 | Geode Capital Management ✦ (passiv) | 3.79M | +0.6% | $32.88M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 7 | Millennium Management ✦ | 2.13M | +5.2% | $18.44M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 8 | Citadel Advisors ✦ | 1.29M | +55.1% | $11.15M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 9 | Renaissance Technologies ✦ | 1.20M | +79.2% | $10.38M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 10 | Morgan Stanley ✦ | 1.08M | n/a | $9.33M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 11 | Goldman Sachs Group ✦ | 789.28K | n/a | $6.84M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 12 | Two Sigma Investments ✦ | 702.00K | +30.2% | $6.09M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Fidelity (FMR) ✦ | 328.64K | +13.4% | $2.85M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 14 | T. Rowe Price ✦ | 191.07K | +4.3% | $1.66M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 179.71K | +921.1% | $1.56M | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 16 | JPMorgan Chase ✦ | 146.04K | n/a | $1.27M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 17 | Point72 Asset Management ✦ | 96.92K | Neu | $840,266 | 0.0% | New | 1 | SEC ↗ ×2 |
| 18 | Wellington Management ✦ | 67.15K | +5.9% | $582,155 | 0.0% | ▲ Add | 5 | SEC ↗ ×4 |
| 19 | Marshall Wace ✦ | 50.59K | Neu | $438,659 | 0.0% | New | 1 | SEC ↗ ×2 |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Point72 Asset Management | $840,266 | 0.0% |
| Marshall Wace | $438,659 | 0.0% |
Ausgestiegen
| Keine erfassten Ausstiege in diesem Quartal. |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 1 Inhaber, 100.30K Anteile, $816 gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.